REGENXBIO to Participate in Upcoming Investor Conferences
Mar 07, 2018 21:05 pm UTC| Business
ROCKVILLE, Md., March 07, 2018 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV®...
Tandy Leather Factory Reports Q4 and FY 2017 Financial Results
Mar 07, 2018 21:05 pm UTC| Business
FORT WORTH, Texas, March 07, 2018 -- Tandy Leather Factory, Inc. (NASDAQ:TLF) today reported financial results for the fourth quarter and year ended December 31, 2017. A conference call will be conducted by senior...
Prothena to Participate in the Barclays Global Healthcare Conference
Mar 07, 2018 21:05 pm UTC| Business
DUBLIN, Ireland, March 07, 2018 -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience...
Aduro Biotech to Present at the 38th Annual Cowen Healthcare Conference
Mar 07, 2018 21:02 pm UTC| Business
BERKELEY, Calif., March 07, 2018 -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Andrea van Elsas, chief scientific officer of Aduro, will present at the 38th Annual Cowen Healthcare Conference in Boston, MA...
Mar 07, 2018 21:02 pm UTC| Business
PRINCETON JUNCTION, N.J., March 07, 2018 -- MISTRAS Group, Inc. (NYSE:MG) will have a conference call on Tuesday, March 13, 2018 at 9:00 a.m. Eastern Time to discuss its results for the fourth quarter and fiscal year...
Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update
Mar 07, 2018 21:02 pm UTC| Business
Two novel anti-epileptic drugs advancing in clinical development; Interim XEN1101 Phase 1 data expected to be released in May 2018 at scientific symposium; Xenon announces new clinical stage ion channel product to...
Esperion to Participate in Fireside Chat at March 2018 Investor Conferences
Mar 07, 2018 21:02 pm UTC| Business
ANN ARBOR, Mich., March 07, 2018 -- Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment...